From: Why tocotrienols work better: insights into the in vitro anti-cancer mechanism of vitamin E
T3 form | Non-mammary cancer cells | IC50[μM] (time of treatments) | References |
---|---|---|---|
δ-T3 | MIA-PaCaa | 28h (48 h) | (Hussein and Mo 2009) |
PANC-1b | 35h (48 h) | ||
BxPC3c | 35h (48 h) | ||
PC3d | 32h (24 h) | (Yu et al. 1999) (Srivastava and Gupta 2006) (Kumar et al. 2006) Recenty reviewed in (Constantinou et al. 2009) | |
PC3d | 25h (48 h) | ||
DU 145e | 20h (24 h) | ||
DU 145e | 27h (48 h) | ||
LNCapg | 26h (24 h) | ||
LNCapg | 19h (48 h) | ||
γ-T3 | SGC 7901f | 27h (72 h) | (Sun et al. 2008) |
PC3d | 33h (24 h) | (Yu et al. 1999) (Srivastava and Gupta 2006) (Kumar et al. 2006) Recenty reviewed in (Constantinou et al. 2009) | |
PC3d | 24h (48 h) | ||
DU 145e | 34h (24 h) | ||
DU 145e | 30h (48 h) | ||
LNCapg | 21h (24 h) | ||
LNCapg | 21h (48 h) | ||
α-T3 | PC3d | >100h (24 h) | |
PC3d | >100h (48 h) | ||
DU 145e | >100h (24 h) | ||
DU 145e | >100h (48 h) | ||
LNCapg | >100h (24 h) | ||
LNCapg | >100h (48 h) | ||
β-T3 | PC3d | 59h (24 h) | |
PC3d | 48h (48 h) | ||
DU 145e | 60h (24 h) | ||
DU 145e | 53h (48 h) | ||
LNCapg | 70h (24 h) | ||
LNCapg | 52h (48 h) |